Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modafinil for treatment of major depressive disorder
IRCT138902301556N15Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of modafinil in major depressive disorder (MDD), sponsored by Tehran University of Medical Sciences. Started Jun 2010; status: completed.
02
Drugs
modafinil
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on IRCT138902301556N15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138902301556N15.